Search

everythinglearnresearchcommunity

for

Search:↓

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

The consensus document recommends a comprehensive treatment plan for Hidradenitis Suppurativa, including various medications, surgery, lifestyle changes, and the need for more research and resources.

A patient with a larger than usual genetic mutation had a broader range of symptoms for a muscle disease.

Testosterone may help increase sexual events for women with low libido due to antidepressants.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Serotonergic antidepressants can significantly increase the risk of erectile dysfunction and have a small risk of causing irreversible sexual dysfunction.

Testosterone therapy is effective and safe for women with low sexual desire, but it's hard to access.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

Topical minoxidil 5% can cause erectile dysfunction and decreased libido.

Serenoa repens may cause long-lasting sexual and psychiatric side effects.

Androgens affect many aspects of female health, and more research is needed to understand their roles and treatment potential.

Post-finasteride syndrome can cause lasting sexual, physical, and mental health issues with limited treatment options.

Mesotherapy is a promising alternative to minoxidil for hair loss with mild side effects.

Drinking alcohol before taking flibanserin does not increase the risk of severe low blood pressure or fainting.

Men may experience long-term sexual dysfunction after stopping Finasteride.

Finasteride reduces prostate cancer risk but may affect ejaculatory volume and requires careful consideration for young men.

Testosterone and its byproducts help support male sexual behavior through different pathways in the brain and body.

Early intervention and protective measures are crucial for managing CIPA due to the lack of pain and standard treatment.

The document sets criteria for diagnosing long-term sexual dysfunctions caused by certain medications.

A female dog with mixed male and female traits was treated successfully with surgery.

Gender-diverse individuals face more depression and anxiety, possibly due to unique stress profiles.

Stem cell treatment improved life quality and sexual function in women with hair loss.

Platelet-rich plasma shows promise in reducing pain for bladder pain syndrome.

Improving prostate and urinary health can enhance sexual function and mental well-being in older men.

Peripheral treatments showed some improvement in sexual dysfunction, but central symptoms remain challenging.